Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • Movers
  • News

Vertex’s Non-Opioid Diabetes Associated Nerve Pain Treatment Candidate Aces Mid-Stage Trial

By Vandana Singh
December 13, 1:30 PM
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) released results from its Phase 2 dose-ranging study of VX-548 (non-opioid pain medicine) for diabetic peripheral neuropathy, a type of nerve damage 

VRTX

Read More
2 minute read
  • Cannabis
  • Health Care
  • Markets
  • News

Charlotte’s Web And DeFloria Launch First Ever Hemp-Based Drug Into Human Trials

By Patricio Liddle
December 13, 12:23 PM
DeFloria and Charlotte's Web launch Phase 1 clinical trial of hemp-based drug AJA001. Explore safety, benefits, and future prospects.

CWBHF

Read More
1 minute read
  • General
  • Health Care
  • M&A
  • News

Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal

By Vandana Singh
December 13, 12:20 PM
Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc.

IART

Read More
1 minute read
  • Contracts
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Small Cap

Why Is Wellness Company Medifast Stock Trading Lower Today?

By Vandana Singh
December 13, 12:11 PM
Virtual primary care services provider LifeMD Inc (NASDAQ: LFMD) announced a strategic alliance with Medifast Inc (NYSE: MED), the health and wellness company known for its habit-based and coach-guided&

LFMD

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Blood Cancer-Focused Shattuck Labs Stock Soaring Today?

By Vandana Singh
December 13, 10:58 AM
Shattuck Labs Inc (NASDAQ: STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk myelodysplastic syndromes (HR-MDS) and TP53 mutant (TP53m) 

STTK

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Penny Stocks

Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant

By Vandana Singh
December 13, 9:58 AM
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records with law enforcement.

AMZN

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Why Is US Pharma Giant Pfizer Stock Trading Lower Today?

By Vandana Singh
December 13, 8:50 AM
Pfizer Inc (NYSE: PFE) provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen Inc (NASDAQ: SGEN) transaction.

PFE

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • M&A
  • Markets
  • Media
  • News

Revived Talks On UK Boots Separation: Walgreens Reportedly Mulls Exit Strategy Amidst IPO Consideration

By Vandana Singh
December 13, 7:53 AM
Walgreens Boots Alliance Inc (NASDAQ: WBA) is reportedly reconsidering plans to part ways with its U.K.

APO

Read More
1 minute read
  • After-Hours Center
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why ReShape Lifesciences Jumped After-Hours

By Ryan Gustafson
December 12, 6:19 PM
ReShape Lifesciences, Inc. (NASDAQ: RSLS) shares are trading higher after the company announced it received FDA PMA supplement approval for its next-generation

RSLS

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Legal
  • M&A
  • Markets
  • Media
  • News

Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage

By Vandana Singh
December 12, 3:12 PM
Illumina Inc (NASDAQ: ILMN) reportedly clashed with EU antitrust regulators, alleging an overreach in their investigation into its

ILMN

Posts pagination

Previous 1 … 98 99 100 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service